Natus Medical Incorporated (NTUS) Research
Natus Medical Incorporated is a global provider of advanced medical device solutions, dedicated to the diagnosis and treatment of conditions affecting the central nervous and sensory systems. The company's offerings are utilized for the screening, detection, therapeutic intervention, ongoing monitoring, and tracking of a wide array of prevalent medical issues. Its product portfolio addresses critical areas such as newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disturbances, and neuromuscular diseases. Natus develops sophisticated computerized neurodiagnostic systems for specialties including audiology, neurology, polysomnography, and neonatology. Furthermore, it supplies software systems designed for the management and tracking of disorders within public health laboratories. Specific solutions encompass electroencephalography (EEG), long-term monitoring, intensive care unit monitoring, electromyography (EMG), comprehensive sleep analysis (polysomnography), and intra-operative monitoring. The company also furnishes products for hearing assessment, screening initiatives, and precision instrument fitting. Additional specialized offerings include jaundice management tools, devices for brain injury, and cutting-edge eye imaging systems specifically engineered for neonatal and pediatric retinal examination. Moreover, Natus provides essential equipment for the daily operations of neonatal intensive care units (NICUs), systems for evaluating balance disorders, and NICVIEW, an innovative live video streaming service that connects families with their infants in the NICU. It also offers computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. The company's diverse clientele includes university medical centers, both public and private hospitals, private physician practices, clinics, and research laboratories worldwide. Established in 1987, the organization was initially known as ALGOTEK Instruments, Inc., before officially changing its name to Natus Medical Incorporated in September 1988. Its corporate headquarters are situated in Middleton, Wisconsin.
Market snapshot
- Symbol
- NTUS
- Price
- $32.96
- Day change
- 0.00%
- Market cap
- $806.2M
- P/E ratio
- 84.98x
- 52-week range
- 32.84-33.07
- Sector
- Healthcare
- Industry
- Medical - Devices
Peer companies
Recent insider activity
- LEVINE JOSHUA — D-Return (37387 shares) on 2022-07-21
- Heine Lisa Wipperman — D-Return (26287 shares) on 2022-07-21
- Sullivan Thomas Joseph — A-Award (648554 shares) on 2022-07-21
- Sullivan Thomas Joseph — D-Return (720903 shares) on 2022-07-21
- Noll Austin Francis III — A-Award (61966 shares) on 2022-07-21
Open Natus Medical Incorporated (NTUS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.